You are here: Industry Insights > AstraZeneca

News List

AstraZeneca and FibroGen receive approval to market roxadustat in China pharmaceutical-technology
December 21, 2018
AstraZeneca and its partner FibroGen Medical Technology Development have obtained approval from China’s National Medical Products Administration (NMPA) to market roxadustat for the treatment of anaemia caused due to chronic kidney disease (CKD).....
AstraZeneca announces positive results from SOLO-3 trial of Lynparza pharmaceutical-technology
December 21, 2018
AstraZeneca and its partner Merck have published positive results from SOLO-3 phase III trial of Lynparza, which is indicated for BRCA-mutated (BRCAm) advanced ovarian cancer.
AstraZeneca, FibroGen give China bragging rights to first-in-class anemia drug approval fiercepharma
December 20, 2018
It is a rare event, if not a singular one in the biopharma world: A first-in-class drug developed by multinational pharma companies was filed first—and now approved first—in China, well before the U.S., EU or Japan.
Feds abandon 11 'white-coat' kickback probes, questioning whistleblower motives instead pharmatimes
December 20, 2018
After digging into almost a dozen whistleblower complaints alleging pharma companies ran kickback schemes with nurse educators as the "payment"—so-called white-coat marketing—the government is backing out.
AstraZeneca and Cancer Research UK open functional genomics centre pharmaceutical
December 13, 2018
AstraZeneca has partnered with Cancer Research UK to open a functional genomics centre of excellence focused on accelerating the discovery and development of new oncology medicines.
AstraZeneca, AVEO Oncology form lung cancer collaboration pharmatimes
December 13, 2018
AVEO Oncology has announced the start of an immuno-oncology focused clinical collaboration with drug giant AstraZeneca (AZ).
Circassia takes on full US rights to AZ’ Tudorza pharmatimes
December 13, 2018
The firm already promotes the COPD therapy in the US under a profit share arrangement covering the drug and fellow COPD therapy Duaklir (aclidinium/formoterol), established by the two companies in April last year.
Group calls for flu shots over AstraZeneca's FluMist this year fiercepharma
December 12, 2018
AstraZeneca’s FluMist has missed two flu seasons in the U.S. due to efficacy problems, and now a group of pediatric experts have recommended injected vaccines over the nasal option for the upcoming season.
AstraZeneca’s Imfinzi fails to meet main goals in head and neck cancer study expressbpd
December 11, 2018
The study, known as ‘EAGLE’, did not improve overall survival compared with standard chemotherapy in patients with the hard-to-treat disease
AstraZeneca, Cancer Research UK Launch Functional Genomics Centre americanpharmaceuticalreview
December 11, 2018
AstraZeneca announced a new collaboration with Cancer Research UK to launch a centre of excellence in genetic screening, cancer modelling and big data processing.....

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page